Commercial determinants of cancer control policy (Eurohealth)
2022 Eurohealth (28.2)
Overview
This Eurohealth special issue seeks to understand the commercial determinants of cancer control policy. This relates to private-sector activities that affect the health of populations. The articles present the dimensions of the commercial determinants and how to govern them along the cancer continuum - from prevention and screening, through integrated treatment and palliative care - to provide a potentially useful descriptive and analytical basis for governments and the international community.
The Observatory is currently planning activities related to this subject or publication. If you would like to hear from us when details become available, please register your interest here.
Contents includes:
- Foreword
- The dark side of the commercial determinants of cancer policy
- Countering corporate tactics for better cancer prevention
- The commercial drivers of cancer screening
- Non-pharmaceutical technologies in cancer care
- Commerical determinants of cancer medicines
- Commercial and social determinants in palliative care
- The role of governments and international agencies
- Ethical questions surrounding the commercial determinants of health